Go back to trials list
Allogeneic Hematopoietic Progenitor Cell Transplantation From Unrelated Donors
Description
The purpose of this study is to provide an opportunity for patients with malignancies or bone marrow failure states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries.same
Trial Eligibility
Inclusion Criteria: > 18 years of Age < 70 years ECOG performance status 0, 1 or 2 Left Ventricular Ejection Fraction > 30% Creatinine clearance > 40ml/min Transaminases < 2X normal Total bilirubin < 2X normal HIV seronegativity Weight < 70kg for cord blood transplantation Ability to cover the cost of the transplant, necessary medications, and transportation/housing. Caregiver must be available while outpatient Exclusion Criteria: Greater than one antigen mismatch at HLA-A, B, C or DR plus one allele mismatch at HLA-A, B, C or DR
Study Info
Organization
Scripps Health
Primary Outcome
Bone Marrow and Peripheral Blood Chimerism
Interventions
Locations Recruiting
Scripps Green Hospital
United States, California, La Jolla
Interested in joining this trial?
Our dedicated patient navigators are here to guide you through the validation and enrollment process with ease.
Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.
Thanks to our HealthTree Community for Multiple Myeloma Sponsors:







.svg_7bb6fd32-1b73-4ca9-9a2f-8fd6fc59d528.png?alt=media)